The U.K.’s emergency authorization of the COVID-19 vaccine from AstraZeneca and the University of Oxford prioritizes widespread vaccination with a flexible dosing schedule that’s supported by recent data showing up to 70% efficacy for a single...

This year’s ASH meeting provides an opportunity to take stock of clinical progress in hot target, modality and disease areas: CD47 inhibitors, allogeneic CAR T cells and sickle cell disease. Abstracts...

COVID-19 has spotlighted the critical role of diagnostics and focused the world’s attention on the threats posed by infectious pathogens. Awareness is good, but what’s really needed to advance diagnostics...

First and foremost, the biopharma industry’s lesson from COVID-19 must be to advocate for the kinds of government engagement and investment that can provide a robust platform of countermeasures standing...

Having turned photosynthetic bacteria into protein production machines, Lumen believes it has cracked the code to making cheap, oral biologics for widespread diseases in the Western and developing worlds....

As pharmas grapple with how to return to work, employees are being given the upper hand in deciding when and how to do so. The result could preface a transformation to a semi-virtual office structure,...

Less than three months after COVID-19 reached pandemic status, and five since the virus was sequenced, drug development has reached the point where hundreds of clinical trials will soon read out. With a pile of...

It’s been a big couple of weeks for COVID-19 vaccine data, and the findings are simultaneously encouraging and disheartening. While they hint that some level of protection is achievable -- by multiple candidates -- more...

As IMV and Vaxart prepare to advance their COVID-19 vaccine candidates into the clinic, monkey data from a Harvard-led team provide not only evidence of protective immunity following COVID-19 resolution, but also an antibody benchmark...

At least six Indian companies are developing or co-developing COVID-19 vaccines, but India’s biggest contribution to fighting the pandemic is likely to come from its manufacturing might. The Serum Institute of India, the world’s largest...